Condition 1: Infertility. Condition 2: Infertility. Female infertility associated with anovulation Female infertility, unspecified
Conditions
Interventions
Intervention 1: All cycles were gently stimulated after baseline
transvaginal ultrasonography
with 100 mg oral
tablets of clomiphen citrate
daily for 5 days starting on
day 3 of the menstrual cycle
Treatment - Drugs
All cycles were gently stimulated after baseline
transvaginal ultrasonography
with 100 mg oral
tablets of clomiphen citrate
daily for 5 days starting on
day 3 of the menstrual cycles and a sta
control group received no medicine.
Sponsors
Individual
Eligibility
Sex/Gender
Female
Age
No minimum to 36 Years
Inclusion criteria
Inclusion criteria: inclusion criteria:normal sonograph;normal fsh , lh @AMH;without cardiac, pulmonary and renal disease;mild endometriosis;normal sperm analysais;normal HSG and exclusion criteria:more than 36 years old;previous ovarian surgery;tubal factor;severe endometriosis; Hypothalamic Amenorrhea ;Endocrine causes of infertility and amenorrhea;patients with more than 3 Follicles with 14 mm diameters;sever oligoasthenospermia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 16 days. Method of measurement: beta HCG>50 milli-international units per milliliter (mIU/ml).;Clinical pregnancy. Timepoint: 6 weeks. Method of measurement: gestational sac in sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Abortion. Timepoint: 20 weeks. Method of measurement: loss of pregnancy before 20 weeks.;Side effects. Timepoint: 9 months. Method of measurement: patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Yasaei Mehrjardi
Shahid Sadoughi University of Medical Science
Outcome results
None listed